Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

LEUKEMIA

NATURE PUBLISHING GROUP

1. Cooperative Research Thematic Network grant of the Red de Cancer (Cancer Network of Excellence RTICC) [RD12/0036/0061]
2. Subdireccion General de Investigacion Sanitaria (Instituto de Salud Carlos III, Spain) [PI15/02062, PI15/01484]
3. CRIS against Cancer foundation [2014/0120]
4. Joan Rodes grant [JR 14/00016]
5. Undergraduate Fellowship [IFI14/00008]